Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Renal Fibrosis and Prediction of Kidney Function Decline: The Role of MRI and Markers of Accelerated Renal Ageing (MARS)

NCT04625140 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT04625140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Renal Fibrosis and Prediction of Kidney Function Decline: The Role of MRI and Markers of Accelerated Renal Ageing (MARS)
Lead sponsor
University Hospital, Akershus
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2021
Completion date
August 30, 2025
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney scarring